cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV ‐1 envelope glycoprotein vaccine candidate

This article is protected by copyright. All rights reserved

Source: Biotechnology and Bioengineering - November 18, 2017 Category: Biomedical Science Authors: Antu K. Dey, Albert Cupo, Gabriel Ozorowski, Vaneet K. Sharma, Anna ‐Janina Behrens, Eden P. Go, Thomas J. Ketas, Anila Yasmeen, Per J. Klasse, Eddy Sayeed, Heather Desaire, Max Crispin, Ian A. Wilson, Rogier W. Sanders, Thomas Hassell, Andrew Ward, Joh Tags: Article Source Type: research